
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
- COVID-19
- New Therapies and Current Patient Management of Lymphomas
- Update on Patient Care Treatment Strategies in Leukemia
- Controversies and Update for Patient Care in Multiple Myeloma
2021 Penn Medicine Update on FLT3i in R/R AML: Gilteritinib Mono and in Combination With Venetoclax, Newer Agents in Frontline Intensive Therapy and Post-transplant Maintenance
125 views
March 2, 2021
Comments 0
Login to view comments.
Click here to Login
Update on Patient Care Treatment Strategies in Leukemia